TrademarkDir
LEVERNA
DEAD

Serial Number

97432424

Owner

Fosun Pharma USA Inc.

Attorney

Perry Gattegno

Filing Date

May 27, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LEVERNA Trademark

Serial Number: 97432424

LEVERNA is a trademark filed by Fosun Pharma USA Inc. on May 27, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Fosun Pharma USA Inc. (13 trademarks)

104 Carnegie Center Drive, Suite 204
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

May 27, 2022

Registration Date

Not Registered

Published for Opposition

January 10, 2023

Goods & Services

Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 13, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 13, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2025 EXRA
SOU EXTENSION 5 GRANTED
Aug 27, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Aug 18, 2025 EEXT
SOU EXTENSION 5 FILED
Aug 17, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 25, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 24, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 27, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 27, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 26, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2023 AITU
NOTICE OF REVIVAL - E-MAILED
Oct 10, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 10, 2023 TPEX
NOTICE OF REVIVAL - E-MAILED
Oct 10, 2023 NREV
PETITION TO REVIVE-GRANTED
Oct 10, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 10, 2023 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2023 ABN6
SOU EXTENSION 1 FILED
Sep 7, 2023 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2022 CNSA
ASSIGNED TO EXAMINER
Dec 5, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2022 NWOS
NEW APPLICATION ENTERED
May 31, 2022 NWAP

Related Trademarks

More from this Owner

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS logo

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS logo

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS

ARCHIMMUNE

ARCHIMMUNE

DAASO

DAASO

DAASO

DAASO

ELSA

ELSA